A subscription to JoVE is required to view this content. Sign in or start your free trial.
* These authors contributed equally
Here, we present a protocol to establish a distal middle cerebral artery occlusion (dMCAO) model through transcranial electrocoagulation in C57BL/6J mice and evaluate the subsequent neurological behavior and histopathological features.
Ischemic stroke remains the predominant cause of mortality and functional impairment among the adult populations globally. Only a minority of ischemic stroke patients are eligible to receive intravascular thrombolysis or mechanical thrombectomy therapy within the optimal time window. Among those stroke survivors, around two-thirds suffer neurological dysfunctions over an extended period. Establishing a stable and repeatable experimental ischemic stroke model is extremely significant for further investigating the pathophysiological mechanisms and developing effective therapeutic strategies for ischemic stroke. The middle cerebral artery (MCA) represents the predominant location of ischemic stroke in humans, with the MCA occlusion serving as the frequently employed model of focal cerebral ischemia. In this protocol, we describe the methodology of establishing the distal MCA occlusion (dMCAO) model through transcranial electrocoagulation in C57BL/6 mice. Since the occlusion site is located at the cortical branch of MCA, this model generates a moderate infarcted lesion restricted to the cortex. Neurological behavioral and histopathological characterization have demonstrated visible motor dysfunction, neuron degeneration, and pronounced activation of microglia and astrocytes in this model. Thus, this dMCAO mouse model provides a valuable tool for investigating the ischemiastroke and worth of popularization.
Stroke is a common acute cerebrovascular disease characterized by high incidences of disability and fatality1. Of all stroke cases, nearly 80% belong to ischemic stroke2. Up to now, intravenous thrombolysis remains one of a limited number of productive approaches for the treatment of acute ischemic stroke. However, the effectiveness of thrombolytic treatment is restricted by the narrow effective time window and the occurrence of hemorrhagic transformation3. In the long-term rehabilitation phase following an ischemic stroke, a considerable number of patients are likely to experience durable neurolo....
The experimental protocol was approved by the Institutional Animal Care and Use Committee of Jianghan University and was conducted in accordance with Experimental Animals Ethical Guidelines issued by the Center for Disease Control of China. Adult male C57BL/6J mice, 10 weeks old, weighted 24-26 g, were used in this protocol. All mice were housed under a 12-h light/dark cycle controlled environment with food and water ad libitum.
1. Preoperative preparation
The key instruments used to perform the dMCAO are the microsurgical instruments set, the isoflurane vaporizer, and the monopolar microsurgical electrocoagulation generator shown in Figure 1. The experimental procedure of this study is illustrated in Figure 2. In brief, a small bone window craniotomy was employed to expose the distal MCA, which was subsequently coagulated to induce permanent focal cerebral ischemia in C57BL/6 mice. Furthermore, the ischemic .......
In the present protocol of the craniotomy electrocoagulation dMCAO model, the surgical procedures are conducted with minimal invasiveness, wherein only a portion of the temporalis muscle is separated to mitigate the adverse effects on masticatory function. The mice all recovered well after the procedure, with no observed instances of feeding difficulties. The MCA can be easily discerned in the temporal bone of the mouse, thereby facilitating precise identification of suitable craniotomy locations. This dMCAO model-induce.......
This study was supported by the Grants from the Nature Science Foundation of Hubei Province (2022CFC057).
....Name | Company | Catalog Number | Comments |
2,3,5-Triphenyltetrazolium Chloride (TTC) | Sigma-Aldrich | 108380 | Dye for TTC staining |
24-well culture plate | Corning (USA) | CLS3527 | Vessel for TTC staining |
4% paraformaldehyde | Wuhan Servicebio Technology Co., Ltd. | G1101 | Tissue fixation |
5% bovine serum albumin | Wuhan BOSTER Bio Co., Ltd. | AR004 | Non-specific antigen blocking |
5-0 Polyglycolic acid suture | Jinhuan Medical Co., Ltd | KCR531 | Material for surgery |
Anesthesia machine | Midmark Corporation | VMR | Anesthetized animal |
Antifade mounting medium | Beyotime Biotech | P0131 | Seal for IF staining |
Automation-tissue-dehydrating machine | Leica Biosystems (Germany) | TP1020 | Dehydrate tissue |
Depilatory cream | Veet (France) | 20220328 | Material for surgery |
Diclofenac sodium gel | Wuhan Ma Yinglong Pharmaceutical  Co., Ltd. | H10950214 | Analgesia for animal |
Drill tip (0.8 mm) | Rwd Life Science Co., Ltd. | Equipment for surgery | |
Eosin staining solution | Wuhan Servicebio Technology Co., Ltd. | G1001 | Dye for H&E staining |
Eye ointment | Guangzhou Pharmaceutical Co., Ltd | H44023098 | Material for surgery |
Fluorescence microscope | Olympus (Japan) | BX51 | Image acquisition |
GFAP Mouse monoclonal antibody | Cell Signaling Technology Inc. (Danvers, MA, USA) | 3670 | Primary antibody for IF staining |
Goat anti-mouse Alexa 488-conjugated IgG | Cell Signaling Technology Inc. (Danvers, MA, USA) | 4408 | Second antibody for IF staining |
Goat anti-rabbit Alexa 594-conjugated IgG | Cell Signaling Technology Inc. (Danvers, MA, USA) | 8889 | Second antibody for IF staining |
Grip strength meter | Shanghai Xinruan Information Technology Co., Ltd. | XR501 | Equipment for behavioral test |
Hematoxylin staining solution | Wuhan Servicebio Technology Co., Ltd. | G1004 | Dye for H&E staining |
Iba1 Rabbit monoclonal antibody | Abcam | ab178846 | Primary antibody for IF staining |
Isoflurane | Rwd Life Science Co., Ltd. | R510-22-10 | Anesthetized animal |
Laser doppler blood flow meter | Moor Instruments (UK) | moorVMS | Blood flow monitoring |
Meloxicam | Boehringer-Ingelheim | J20160020 | Analgesia for animal |
Microdrill | Rwd Life Science Co., Ltd. | 78001 | Equipment for surgery |
Microsurgical instruments set | Rwd Life Science Co., Ltd. | SP0009-R | Equipment for surgery |
Microtome | Thermo Fisher Scientific (USA) | HM325 | Tissue section production |
Microtome blade | Leica Biosystems (Germany) | 819 | Tissue section production |
Monopolar electrocoagulation generator | Spring Scenery Medical Instrument Co., Ltd. | CZ0001 | Equipment for surgery |
Mupirocin ointment | Tianjin Smith Kline & French Laboratories Ltd. | H10930064 | Anti-infection for animal |
NeuN Rabbit monoclonal antibody | Cell Signaling Technology Inc. (Danvers, MA, USA) | 24307 | Primary antibody for IF staining |
Neutral balsam | Absin Bioscience | abs9177 | Seal for H&E staining |
Paraffin embedding center | Thermo Fisher Scientific (USA) | EC 350 | Produce paraffin blocks |
Pentobarbital sodium | Sigma-Aldrich | P3761 | Euthanized animal |
Phosphate buffered saline | Shanghai Beyotime Biotech Co., Ltd | C0221A | Rinsing for tissue section |
Shaver | Shenzhen Codos Electrical Appliances Co.,Ltd. | CP-9200 | Equipment for surgery |
Sodium citrate solution | Shanghai Beyotime Biotech Co., Ltd. | P0083 | Antigen retrieval for IF staining |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved